Cite
HARVARD Citation
Macy, M. et al. (n.d.). Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. European journal of cancer. pp. S28-S29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macy, M. et al. (n.d.). Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. European journal of cancer. pp. S28-S29. [Online].